Atria Investments’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
RA
Atria Investments's CLB Position: Q3 2024 in Review
Atria Investments sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 11,976 shares — an estimated $243K sold.
Atria Investments first reported a position in CLB in Q2 2013 and held it in 16 quarters. The position peaked at $1.1M in Q1 2022. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.
- Atria Investments reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
- Atria Investments sold 11,976 Core Laboratories shares in Q3 2024, an estimated $243K.
- Atria Investments first reported a position in Core Laboratories in Q2 2013 and held it in 16 quarters.
- Atria Investments's Core Laboratories position peaked at $1.1M in Q1 2022.
- 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.
Based on Atria Investments's 13F filing for Q3 2024, filed 1 Nov 2024.